Business ❯ Biotechnology

Biopharmaceuticals

Manufacturing Antibody Drugs Biosimilars Metabolic Diseases Cancer Research Corporate Culture Muscle Activators

Propanc Biopharma Lines Up Up to $100 Million From Hexstone to Launch Digital-Asset Treasury and Speed PRP Toward Trials

Investors reacted to dilution risk as the deal leaves up to $99 million available over the next 12 months.

Cytokinetics Investors Urged to Seek Counsel Before Nov. 17 Lead-Plaintiff Deadline in Aficamten Case